Skip to content

Electroacupuncture relieves urinary tract symptoms under benign prostatic hyperplasia: randomized controlled trial

Electroacupuncture relieves urinary tract symptoms under benign prostatic hyperplasia: randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069335
Enrollment
Unknown
Registered
2023-03-14
Start date
2023-03-14
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

Control group:sham acupuncture

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for benign prostatic hyperplasia (BPH); 2. Male patients, aged 60 to 80 years old (including 60 and 80 years old); 3. Lower urinary tract symptoms (LUTS) persist for 3 months or more; 4. The total score of the International Prostate Symptom Score (IPSS) scale >= 8 points; 5. Measured by abdominal ultrasound, prostate volume >= 20mL; 6. Urine flow rate determination, the maximum urine flow rate <= 15mL/s.

Exclusion criteria

Exclusion criteria: 1. Residual urine volume >= 150mL; 2. Acute urinary retention or history of indwelling catheters in the past 3 months (except for one-time indwelling catheterization during surgery); 3. Prostate cancer or prostate-specific antigen >= 4ng/mL; 4. Neurogenic lower urinary tract dysfunction; Prostatitis; Uncontrolled symptomatic urinary tract infections; Urethral stricture; bladder diverticulum; Bladder stones; Bladder cancer; history of genitourinary (prostate, bladder, urethra, etc.) surgery; 5. Acupuncture treatment of benign prostatic hyperplasia (BPH) within the past 30 days, or use a-receptor blockers or other drugs specific for the treatment of lower urinary tract symptoms (LUTS) within 3 days; 6. Severe respiratory, circulatory, metabolic and psychiatric diseases, or liver function, kidney function, coagulation dysfunction, or accompanied by obvious cognitive dysfunction; 7. Those who have a pacemaker installed, or are allergic to metal or severely afraid of needles, and cannot tolerate electroacupuncture treatment.

Design outcomes

Primary

MeasureTime frame
International Prostate Symptom Score, IPSS;

Secondary

MeasureTime frame
BPH-II;International Index of Erectile Function-5, IIEF-5;Hospital Anxiety and Depression Scale, HADS;

Countries

China

Contacts

Public ContactJianqin Lyu

West China Hospital, Sichuan University

372651647@qq.com+86 138 8069 7657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026